株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

上部消化管 (GI) :上部消化管向けセルフケア市場の調査

Upper GIs: Investigating the Self-Care Market for Upper Gastrointestinals

発行 Nicholas Hall & Company 商品コード 572132
出版日 ページ情報 英文 308 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
上部消化管 (GI) :上部消化管向けセルフケア市場の調査 Upper GIs: Investigating the Self-Care Market for Upper Gastrointestinals
出版日: 2017年12月21日 ページ情報: 英文 308 Pages
概要

当レポートでは、世界における制酸薬、整腸剤、制嘔吐剤、消化酵素、肝臓 & 胆汁治療薬を含む消化管市場について、最新の科学的研究と主要ブランドのケーススタディ、規制の発展、成功要因、売上高、NPDおよび広告活動などを詳細に調査しています。

エグゼクティブサマリー

主な上部GI市場

  • オーストラリア
  • ブラジル
  • カナダ
  • 中国
  • フランス
  • ドイツ
  • インド
  • インドネシア
  • イタリア
  • 日本
  • ポーランド
  • ロシア
  • 韓国
  • 英国
  • 米国

科学的調査

ブランドのケーススタディ

  • Dramamine (Prestige Brands, J&J)
  • Eno (GSK)
  • Essentiale (Sanofi)
  • Gaviscon (RB, others)
  • Maalox (Sanofi)
  • Nexium (Pfizer)
  • Pepcid (J&J) (1pp)
  • Talcid (Bayer) (1pp)

展望

  • 世界における上部GIの展望
  • 世界における上部GIの売上予測:カテゴリー別
  • 世界における上部GIの売上予測:地域別
  • 主要市場の展望
  • アジア太平洋の上部GIの売上予測
  • 北米の上部GIの売上予測
  • 西欧の上部GIの売上予測
  • 中東欧の上部GIの売上予測
  • ラテンアメリカの上部GIの売上予測
  • 格差が残るものの、多くの市場においてPPI市場が存在
  • 機会 & 脅威
目次

This report is an in-depth exploration of the Gatrointestinals market, including antacids, antiflatulents, antinauseants, digestive enzymes and liver & bile remedies and includes coverage of 15 major markets from across the globe, with topline sales, brand performances, regulatory developments, launches and ad campaigns.

With mid-year sales from DB6 2017, data will include topline historical sales for region, country and category, plus individual brand performances and forecasts to 2021 and 2026 for all categories and countries, plus a look ahead at what the future holds for the GI market globally.

The report will also include: an in-depth look at the latest scientific studies and case studies of key brands, highlighting success factors, sales, NPD and advertising activity.

Table of Contents

  • Definitions & methodology

Executive summary (21 pages)

  • Global upper GIs market
  • Global upper GIs sales mid-2016 & mid-2017
  • Global upper GIs sales by major region mid-2017
  • Global upper GIs sales by category mid-2017
  • Global upper GIs sales by region mid-2017
  • Net contribution categories to global upper GIs growth mid-2017
  • Antacids
  • Global antacids sales mid-2016 & mid-2017
  • Global antacids sales by major region mid-2017
  • Antacids trends in key markets
  • Leading antacids markets mid-2017
  • Global leading antacids 2016
  • H2 antagonists struggling to find a niche in many markets
  • Antiflatulents Global antiflatulents sales mid-2016 & mid-2017 Global antiflatulents sales by major region mid-2017
  • Global leading antiflatulents 2016
  • Antinauseants Global antinauseants sales mid-2016 & mid-2017 Global antinauseants sales by major region mid-2017
  • Antinauseants trends in key markets
  • Global leading antinauseants 2016
  • Digestive enzymes Global digestive enzymes sales mid-2016 & mid-2017
  • Global digestive enzymes sales by major region mid-2017 Global leading digestive enzymes 2016
  • Liver & bile remedies Global liver & bile remedies sales mid-2016 & mid-2017
  • Global liver & bile remedies sales by major region mid-2017
  • Liver & bile remedies trends in key markets Leading liver & bile markets mid-2017
  • Global leading liver & bile remedies 2016 New Product Development driving sales in some markets Leading marketers & brands Global leading upper GIs marketers 2016 GSK upper GIs sales by brand 2016
  • Sanofi upper GIs sales by brand 2016 Pfizer upper GIs sales by brand 2016 P&G upper GIs sales by brand 2016 Bayer upper GIs sales by brand 2016 Scientific studies Global outlook for upper GIs Global forecast upper GIs sales by category 2016-26 Global forecast upper GIs sales by region 2016-26

Leading Upper GIs Markets

Australia (12 pages)

  • Overview (4pp) Australia upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Australia Category overview Australia upper GIs sales by category mid-2017 Growth drivers & negative factors Australia leading upper GIs marketers mid-2017 Australia leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Australia Australia upper GIs sales by pharmacy channel 2016
  • Antacids (3pp) Key antacids trends Australia antacids sales mid-2016 & mid-2017 Australia top brands' share of antacids sales mid-2017 Australia leading antacids mid-2017 Australia antacids sales by segment 2016 Antinauseants (1pp) Key antinauseants trends Australia antinauseants sales mid-2016 & mid-2017 Australia leading antinauseants mid-2017 Digestive enzymes (1pp) Digestive enzymes category underdeveloped, but sees some launch activity
  • Liver & bile remedies (2pp) Key liver & bile remedies trends Australia liver & bile remedies sales mid-2016 & mid-2017 Australia liver & bile remedies brands mid-2017 Outlook (1pp)
  • Future is steady growth, with room for category development Australia forecast upper GIs sales 2021-26

Brazil (13 pages)

  • Overview (4pp) Brazil upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Brazil Category overview Brazil upper GIs sales by category mid-2017 Growth drivers & negative factors Brazil leading upper GIs marketers mid-2017 Brazil leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Brazil Brazil upper GIs sales by pharmacy channel 2016
  • Antacids (3pp) Key antacids trends
  • Brazil antacids sales mid-2016 & mid-2017 Brazil top brands' share of antacids sales mid-2017 Brazil leading antacids mid-2017
  • Antiflatulents (1pp) Key antiflatulents trends Brazil antiflatulents sales mid-2016 & mid-2017 Brazil leading antiflatulents mid-2017 Digestive enzymes (2pp) Key digestive enzymes trends Brazil digestive enzymes sales mid-2016 & mid-2017 Brazil leading digestive enzymes mid-2017
  • ANVISA publishes 2015 report clarifying enzyme regulations
  • Liver & bile remedies (2pp) Key liver & bile remedies trends Brazil liver & bile remedies sales mid-2016 & mid-2017 Brazil liver & bile remedies brands mid-2017 Outlook (1pp)
  • Numerous avenues for growth, with potential for future switches Brazil forecast upper GIs sales 2021-26

Canada (12 pages)

  • Overview (4pp) Canada upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Canada Category overview Canada upper GIs sales by category mid-2017 Growth drivers & negative factors Canada leading upper GIs marketers mid-2017 Canada leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Canada Canada upper GIs sales by pharmacy channel 2016
  • Antacids (4pp) Key antacids trends Canada antacids sales mid-2016 & mid-2017 Canada top brands' share of antacids sales mid-2017 Canada leading antacids mid-2017 Canada antacids sales by segment 2016
  • Antiflatulents (1pp) Key antiflatulents trends Canada antiflatulents sales mid-2016 & mid-2017 Canada leading antiflatulents mid-2017 Antinauseants (1pp) Key antinauseants trends Canada antinauseants sales mid-2016 & mid-2017 Canada leading antinauseants mid-2017 Digestive enzymes (1pp) Key digestive enzymes trends
  • Canada digestive enzymes sales mid-2016 & mid-2017 Canada leading digestive enzymes mid-2017 Outlook (1pp)
  • Low growth, although potential exists for market revival Canada forecast upper GIs sales 2021-26

China (18 pages)

  • Overview (5pp) China upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in China Category overview China upper GIs sales by category mid-2017 Growth drivers & negative factors China leading upper GIs marketers mid-2017 China leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in China China upper GIs sales by pharmacy channel 2016
  • Chinese government attempts to revive traditional medicine with new TCM law in 2017
  • Antacids (5pp) Key antacids trends China antacids sales mid-2016 & mid-2017 China top brands' share of antacids sales mid-2017 China leading antacids mid-2017 China antacids sales by segment 2016
  • Antinauseants (2pp) Key antinauseants trends China antinauseants sales mid-2016 & mid-2017
  • China top brands' share of antinauseants sales mid-2017 China leading antinauseants mid-2017 Digestive enzymes (1pp) Key digestive enzymes trends China digestive enzymes sales mid-2016 & mid-2017
  • China top brands' share of digestive enzymes sales mid-2017 China leading digestive enzymes mid-2017 Liver & bile remedies (3pp) Key liver & bile remedies trends China liver & bile remedies sales mid-2016 & mid-2017
  • China top brands' share of liver & bile remedies sales mid-2017 China leading liver & bile remedies mid-2017
  • Other GIs (1pp)
  • Brand case study: Motilium (Xian-Janssen / J&J)
  • Motilium sales mid-2016 & mid-2017
  • Outlook (1pp)
  • New TCM Law in 2017 may see a revival of traditional medicines in modern Chinese culture China forecast upper GIs sales 2021-26

France (15 pages)

  • Overview (4pp) France upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in France Category overview France upper GIs sales by category mid-2017 Growth drivers & negative factors France leading upper GIs marketers mid-2017 France leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in France France upper GIs sales by pharmacy channel 2016
  • Upper GIs available for self-selection in pharmacies
  • Antacids (3pp) Key antacids trends France antacids sales mid-2016 & mid-2017 France top brands' share of antacids sales mid-2017 France leading antacids mid-2017 France antacids sales by segment 2016
  • Antiflatulents (2pp) Key antiflatulents trends France antiflatulents sales mid-2016 & mid-2017
  • France top brands' share of antiflatulents sales mid-2017 France leading antiflatulents mid-2017 Antinauseants (2pp) Key antinauseants trends France antinauseants sales mid-2016 & mid-2017
  • France top brands' share of antinauseants sales mid-2017 France leading antinauseants mid-2017 Digestive enzymes (1pp) Key digestive enzymes trends France digestive enzymes sales mid-2016 & mid-2017 France leading digestive enzymes mid-2017 Liver & bile remedies (2pp) Key liver & bile remedies trends France liver & bile remedies sales mid-2016 & mid-2017
  • France top brands' share of liver & bile remedies sales mid-2017 France leading liver & bile remedies mid-2017
  • Outlook (1pp)
  • Difficult times ahead for French upper GIs market France forecast upper GIs sales 2021-26

Germany (20 pages)

  • Overview (4pp) Germany upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Germany Category overview Germany upper GIs sales by category mid-2017 Growth drivers & negative factors Germany leading upper GIs marketers mid-2017
  • Germany leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Germany Germany upper GIs sales by pharmacy channel 2016
  • Upper GIs available for self-selection in pharmacies
  • Antacids (4pp) Key antacids trends Germany antacids sales mid-2016 & mid-2017 Germany top brands' share of antacids sales mid-2017 Germany leading antacids mid-2017 Germany antacids sales by segment 2016
  • Antiflatulents (2pp) Key antiflatulents trends Germany antiflatulents sales mid-2016 & mid-2017
  • Germany top brands' share of antiflatulents sales mid-2017 Germany leading antiflatulents mid-2017 Antinauseants (2pp) Key antinauseants trends Germany antinauseants sales mid-2016 & mid-2017
  • Germany top brands' share of antinauseants sales mid-2017 Germany leading antinauseants mid-2017 Digestive enzymes (3pp) Key digestive enzymes trends Germany digestive enzymes sales mid-2016 & mid-2017
  • Germany top brands' share of digestive enzymes sales mid-2017 Germany leading digestive enzymes mid-2017 Liver & bile remedies (3pp) Key liver & bile remedies trends Germany liver & bile remedies sales mid-2016 & mid-2017
  • Germany top brands' share of liver & bile remedies sales mid-2017 Germany leading liver & bile remedies mid-2017
  • Other GIs (1pp)
  • Brand case study: Iberogast (Bayer)
  • Iberogast sales mid-2016 & mid-2017
  • Outlook (1pp)
  • Sales will stabilise, although organic growth opportunities are likely to remain elusive Germany forecast upper GIs sales 2021-26

India (18 pages)

  • Overview (4pp) India upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in India Category overview India upper GIs sales by category mid-2017 Growth drivers & negative factors India leading upper GIs marketers mid-2017 India leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in India India upper GIs sales by pharmacy channel 2016
  • OTC classification in India
  • Antacids (6pp) Key antacids trends India antacids sales mid-2016 & mid-2017 India top brands' share of antacids sales mid-2017 India leading antacids mid-2017 India antacids sales by segment 2016 Digestive enzymes (2pp) Key digestive enzymes trends India digestive enzymes sales mid-2016 & mid-2017 India leading digestive enzymes mid-2017 Liver & bile remedies (3pp) Key liver & bile remedies trends India liver & bile remedies sales mid-2016 & mid-2017
  • India top brands' share of liver & bile remedies sales mid-2017 India leading liver & bile remedies mid-2017
  • More marketers are positioning their brands to prevent hangovers and be used for detox
  • Other GIs (2pp)
  • Key trends
  • India traditional digestive remedies sales mid-2016 & mid-2017
  • India leading traditional digestive remedies mid-2017
  • Outlook (1pp)
  • Marketers are adapting to changing consumer preferences India forecast upper GIs sales 2021-26

Indonesia (13 pages)

  • Overview (4pp) Indonesia upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Indonesia Category overview Indonesia upper GIs sales by category mid-2017 Growth drivers & negative factors Indonesia leading upper GIs marketers mid-2017 Indonesia leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Indonesia Indonesia upper GIs sales by pharmacy channel 2016
  • Antacids (4pp) Key antacids trends Indonesia antacids sales mid-2016 & mid-2017 Indonesia top brands' share of antacids sales mid-2017 Indonesia leading antacids mid-2017 Indonesia antacids sales by segment 2016 Antinauseants (1pp) Key antinauseants trends Indonesia antinauseants sales mid-2016 & mid-2017 Indonesia leading antinauseants mid-2017 Digestive enzymes (1pp)
  • Key digestive enzymes trends Indonesia digestive enzymes sales mid-2016 & mid-2017
  • Indonesia top brands' share of digestive enzymes sales mid-2017 Indonesia leading digestive enzymes mid-2017 Liver & bile remedies (2pp) Key liver & bile remedies trends Indonesia liver & bile remedies sales mid-2016 & mid-2017
  • Indonesia top brands' share of liver & bile remedies sales mid-2017 Indonesia leading liver & bile remedies mid-2017
  • Outlook (1pp)
  • Naturally-formulated products will drive growth as consumers increasingly look to herbal-based remedies Indonesia forecast upper GIs sales 2021-26

Italy (20 pages)

  • Overview (4pp) Italy upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Italy Category overview Italy upper GIs sales by category mid-2017 Growth drivers & negative factors Italy leading upper GIs marketers mid-2017
  • 2017 court ruling means SOP-status brands can now be advertised Italy leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Italy Italy upper GIs sales by pharmacy channel 2016
  • Antacids (5pp) Key antacids trends Italy antacids sales mid-2016 & mid-2017 Italy top brands' share of antacids sales mid-2017 Italy leading antacids mid-2017 Italy antacids sales by segment 2016
  • Antiflatulents (3pp) Key antiflatulents trends Italy antiflatulents sales mid-2016 & mid-2017
  • Italy top brands' share of antiflatulents sales mid-2017 Italy leading antiflatulents mid-2017 Antinauseants (2pp) Key antinauseants trends Italy antinauseants sales mid-2016 & mid-2017
  • Italy top brands' share of antinauseants sales mid-2017 Italy leading antinauseants mid-2017 Digestive enzymes (2pp) Key digestive enzymes trends Italy digestive enzymes sales mid-2016 & mid-2017
  • Italy top brands' share of digestive enzymes sales mid-2017 Italy leading digestive enzymes mid-2017 Liver & bile remedies (3pp)
  • Key liver & bile remedies trends Italy liver & bile remedies sales mid-2016 & mid-2017
  • Italy top brands' share of liver & bile remedies sales mid-2017 Italy leading liver & bile remedies mid-2017
  • Outlook (1pp)
  • Promotional support, NPD and newer formulas to pave the way to growth Italy forecast upper GIs sales 2021-26

Japan (13 pages)

  • Overview (4pp) Japan upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Japan Category overview Japan upper GIs sales by category mid-2017 Growth drivers & negative factors Japan leading upper GIs marketers mid-2017 Japan leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Japan Japan upper GIs sales by pharmacy channel 2016
  • Antacids (5pp) Key antacids trends Japan antacids sales mid-2016 & mid-2017 Japan top brands' share of antacids sales mid-2017 Japan leading antacids mid-2017 Japan antacids sales by segment 2016 Antinauseants (2pp) Key antinauseants trends Japan antinauseants sales mid-2016 & mid-2017
  • Japan top brands' share of antinauseants sales mid-2017 Japan leading antinauseants mid-2017 Other GIs (1pp) Key trends
  • Japan traditional digestive remedies sales mid-2016 & mid-2017
  • Japan leading traditional digestive remedies mid-2017
  • Outlook (1pp)
  • Potential for switch and NPD to expand relatively conservative market Japan forecast upper GIs sales 2021-26

Poland (14 pages)

  • Overview (4pp) Poland upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Poland Category overview Poland upper GIs sales by category mid-2017 Growth drivers & negative factors Poland leading upper GIs marketers mid-2017 Poland leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Poland Poland upper GIs sales by pharmacy channel 2016
  • Antacids (3pp) Key antacids trends Poland antacids sales mid-2016 & mid-2017 Poland top brands' share of antacids sales mid-2017 Poland leading antacids mid-2017 Poland antacids sales by segment 2016
  • Antiflatulents (2pp) Key antiflatulents trends Poland antiflatulents sales mid-2016 & mid-2017
  • Poland top brands' share of antiflatulents sales mid-2017 Poland leading antiflatulents mid-2017 Antinauseants (1pp) Key antinauseants trends Poland antinauseants sales mid-2016 & mid-2017 Poland leading antinauseants mid-2017 Digestive enzymes (1pp) Key digestive enzymes trends Poland digestive enzymes sales mid-2016 & mid-2017 Poland leading digestive enzymes mid-2017 Liver & bile remedies (2pp) Key liver & bile remedies trends Poland liver & bile remedies sales mid-2016 & mid-2017
  • Poland top brands' share of liver & bile remedies sales mid-2017 Poland leading liver & bile remedies mid-2017
  • Outlook (1pp)
  • Solid growth forecast for upper GIs, although innovation needed to unlock potential Poland forecast upper GIs sales 2021-26

Russia (21 pages)

  • Overview (5pp) Russia upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in Russia Category overview Russia upper GIs sales by category mid-2017 Growth drivers & negative factors Russia leading upper GIs marketers mid-2017 Russia leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in Russia Russia upper GIs sales by pharmacy channel 2016
  • Russia may allow home delivery of OTCs in 2018, subject to final approval
  • Antacids (4pp) Key antacids trends Russia antacids sales mid-2016 & mid-2017 Russia top brands' share of antacids sales mid-2017 Russia leading antacids mid-2017
  • Antiflatulents (2pp) Key antiflatulents trends Russia antiflatulents sales mid-2016 & mid-2017
  • Russia top brands' share of antiflatulents sales mid-2017 Russia leading antiflatulents mid-2017 Antinauseants (2pp) Key antinauseants trends Russia antinauseants sales mid-2016 & mid-2017
  • Russia top brands' share of antinauseants sales mid-2017 Russia leading antinauseants mid-2017 Digestive enzymes (3pp) Key digestive enzymes trends Russia digestive enzymes sales mid-2016 & mid-2017
  • Russia top brands' share of digestive enzymes sales mid-2017 Russia leading digestive enzymes mid-2017 Liver & bile remedies (4pp) Key liver & bile remedies trends Russia liver & bile remedies sales mid-2016 & mid-2017
  • Russia top brands' share of liver & bile remedies sales mid-2017 Russia leading liver & bile remedies mid-2017
  • Outlook (1pp)
  • Differentiating brands via new positionings, formula and high-profile promotion is key to success Russia forecast upper GIs sales 2021-26

South Korea (21 pages)

  • Overview (4pp) South Korea upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in South Korea Category overview South Korea upper GIs sales by category mid-2017 Growth drivers & negative factors South Korea leading upper GIs marketers mid-2017 South Korea leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in South Korea South Korea upper GIs sales by pharmacy channel 2016
  • Antacids (5pp) Key antacids trends South Korea antacids sales mid-2016 & mid-2017 South Korea top brands' share of antacids sales mid-2017 South Korea leading antacids mid-2017
  • South Korea antacids sales by segment 2016
  • RB sales plummet after boycott of products
  • Antiflatulents (1pp) Key antiflatulents trends South Korea antiflatulents sales mid-2016 & mid-2017
  • South Korea top brands' share of antiflatulents sales mid-2017 South Korea leading antiflatulents mid-2017 Antinauseants (1pp) Key antinauseants trends South Korea antinauseants sales mid-2016 & mid-2017
  • South Korea leading antinauseants mid-2017 Digestive enzymes (3pp) Key digestive enzymes trends South Korea digestive enzymes sales mid-2016 & mid-2017
  • South Korea top brands' share of digestive enzymes sales mid-2017 South Korea leading digestive enzymes mid-2017 Liver & bile remedies (4pp) Key liver & bile remedies trends South Korea liver & bile remedies sales mid-2016 & mid-2017
  • South Korea top brands' share of liver & bile remedies sales mid-2017 South Korea leading liver & bile remedies mid-2017
  • Other GIs (2pp)
  • Key trends
  • South Korea traditional digestive remedies sales mid-2016 & mid-2017
  • South Korea leading traditional digestive remedies mid-2017
  • Outlook (1pp)
  • Novel formulas and emotive promotion are key to battling generics and generating consumer interest South Korea forecast upper GIs sales 2021-26

UK (15 pages)

  • Overview (4pp) UK upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in UK Category overview UK upper GIs sales by category mid-2017 Growth drivers & negative factors UK leading upper GIs marketers mid-2017 UK leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in UK UK upper GIs sales by pharmacy channel 2016
  • Antacids (5pp) Key antacids trends UK antacids sales mid-2016 & mid-2017 UK top brands' share of antacids sales mid-2017 UK leading antacids mid-2017
  • UK antacids sales by segment 2016
  • Antiflatulents (2pp) Key antiflatulents trends UK antiflatulents sales mid-2016 & mid-2017
  • UK top brands' share of antiflatulents sales mid-2017 UK leading antiflatulents mid-2017 Antinauseants (1pp) Key antinauseants trends UK antinauseants sales mid-2016 & mid-2017
  • UK top brands' share of antinauseants sales mid-2017
  • UK leading antinauseants mid-2017 Digestive enzymes (1pp)
  • Key digestive enzymes trends UK digestive enzymes sales mid-2016 & mid-2017 UK leading digestive enzymes mid-2017 Liver & bile remedies (1pp) Key liver & bile remedies trends UK liver & bile remedies sales mid-2016 & mid-2017
  • UK top brands' share of liver & bile remedies sales mid-2017 UK leading liver & bile remedies mid-2017
  • Outlook (1pp)
  • Invigorating categories with niche launches and addressing safety concerns key to growth UK forecast upper GIs sales 2021-26

USA (21 pages)

  • Overview (4pp) USA upper GIs sales mid-2016 & mid-2017 3 key upper GIs trends in USA Category overview USA upper GIs sales by category mid-2017 Growth drivers & negative factors USA leading upper GIs marketers mid-2017 USA leading upper GIs brands mid-2017 Legal status of key upper GIs ingredients in USA USA upper GIs sales by pharmacy channel 2016
  • Antacids (8pp) Key antacids trends USA antacids sales mid-2016 & mid-2017 USA top brands' share of antacids sales mid-2017 USA leading antacids mid-2017
  • USA antacids sales by segment 2016
  • Call for cancer warnings on heartburn OTCs
  • OTC combinations not "rational" for upset stomach
  • Antiflatulents (3pp) Key antiflatulents trends USA antiflatulents sales mid-2016 & mid-2017
  • USA top brands' share of antiflatulents sales mid-2017 USA leading antiflatulents mid-2017 Antinauseants (2pp) Key antinauseants trends USA antinauseants sales mid-2016 & mid-2017
  • USA top brands' share of antinauseants sales mid-2017
  • USA leading antinauseants mid-2017 Digestive enzymes (2pp) Key digestive enzymes trends USA digestive enzymes sales mid-2016 & mid-2017 USA leading digestive enzymes mid-2017 Liver & bile remedies (1pp) Key liver & bile remedies trends
  • USA liver & bile remedies sales mid-2016 & mid-2017 USA leading liver & bile remedies mid-2017
  • Outlook (1pp)
  • Brands must overcome the private label challenge USA forecast upper GIs sales 2021-26

Scientific Studies (10 pages)

  • Introduction
  • Liver Health
  • Non-Alcoholic Fatty Liver Disease
  • Curcumin
  • Omega-3
  • Glutamine may protect against NASH progression
  • Liver health - Hangover remedies
  • Dihydromyricetin
  • Nutrient-rich supplement claims to counter the causes of a hangover
  • Proton Pump Inhibitors (PPIs)
  • Key Global Switch Activity for PPIs
  • PPIs & bone fractures
  • PPIs & dementia
  • PPIs & mortality
  • New technology offers some solutions to GI problems
  • Scientific studies stress the necessity of liver health supplements as consumer habits impact health

Brand case studies (13 pages)

Dramamine (Prestige Brands, J&J) (1pp)

  • Dramamine upper GIs sales 2012-16
  • Dramamine leading upper GIs markets mid-2017
  • Success factors

Eno (GSK) (2pp)

  • Eno upper GIs sales 2012-16
  • Eno leading upper GIs markets mid-2017
  • Success factors

Essentiale (Sanofi) (2pp)

  • Essentiale upper GIs sales 2012-16
  • Essentiale leading upper GIs markets mid-2017
  • Success factors

Gaviscon (RB, others) (2pp)

  • Gaviscon upper GIs sales 2012-16
  • Gaviscon leading upper GIs markets mid-2017
  • Success factors

Maalox (Sanofi) (2pp)

  • Maalox upper GIs sales 2012-16
  • Maalox leading upper GIs markets mid-2017
  • Success factors

Nexium (Pfizer) (2pp)

  • Nexium upper GIs sales 2012-16
  • Nexium leading upper GIs markets mid-2017
  • Success factors

Pepcid (J&J) (1pp)

  • Pepcid upper GIs sales 2012-16
  • Pepcid leading upper GIs markets mid-2017
  • Success factors

Talcid (Bayer) (1pp)

  • Talcid upper GIs sales 2012-16
  • Talcid leading upper GIs markets mid-2017
  • Success factors

Outlook (10 pages)

  • Global outlook for upper GIs
  • Global forecast upper GIs sales by category 2021-26
  • Global forecast upper GIs sales by region 2021-26
  • Outlook across key markets
  • Asia-Pacific forecast upper GIs sales 2021-26
  • North America forecast upper GIs sales 2021-26
  • Western Europe forecast upper GIs sales 2021-26
  • C&E Europe forecast upper GIs sales 2021-26
  • Latin America forecast upper GIs sales 2021-26
  • PPIs segment exists in many markets, although key gaps remain
  • Opportunities & threats
Back to Top